What are the typical presentation features and management steps for diabetic ketoacidosis?

Diabetic Ketoacidosis: Presentation and Management

Diagnose DKA when blood glucose is ≥250 mg/dL, venous pH <7.3, bicarbonate <15 mEq/L, and moderate ketonuria or ketonemia are present; immediately initiate continuous IV insulin infusion (except in mild cases) along with aggressive fluid resuscitation to prevent mortality from severe acidosis and dehydration. 1

Clinical Presentation

Key Diagnostic Features

DKA presents with the classic triad of:

• Hyperglycemia (≥250 mg/dL)
• Metabolic acidosis (venous pH <7.3, bicarbonate <15 mEq/L)
• Ketonemia/ketonuria (moderate to large) 1

Physical Examination Findings

Look specifically for:

• Kussmaul respirations (deep, rapid breathing as respiratory compensation)
• Dehydration signs (dry mucous membranes, poor skin turgor, tachycardia)
• Altered mental status (ranges from alert to obtunded; severe cases may have pH <7.0)
• Abdominal pain (common, especially in children)
• Fruity breath odor (acetone) 1, 2

Critical caveat: Patients can remain alert and oriented even with extreme acidemia (pH 6.8-7.0) if they maintain adequate respiratory compensation through Kussmaul breathing—do not assume severe acidosis always means altered consciousness 3.

Initial Diagnostic Workup

Obtain immediately after history and physical:

• Blood glucose
• Venous blood gas (arterial not necessary for monitoring; venous pH typically 0.03 units lower)
• Complete metabolic panel (electrolytes, BUN, creatinine, calcium, phosphorus)
• Urinalysis
• Calculate anion gap 1

Monitor every 2-4 hours: electrolytes, glucose, BUN, creatinine, osmolality, venous pH, and anion gap 1

Monitoring Ketones: Important Pitfall

Use beta-hydroxybutyrate (β-OHB) blood measurement, NOT nitroprusside urine/serum ketone tests. The nitroprusside method only detects acetoacetate and acetone but misses β-OHB (the predominant ketoacid in DKA). During treatment, β-OHB converts to acetoacetate, which paradoxically makes nitroprusside tests appear worse even as the patient improves—this can mislead you into thinking therapy is failing 1.

Management Algorithm

Step 1: Fluid Resuscitation (FIRST PRIORITY)

• Initiate immediately before insulin in most cases
• Use isotonic saline (0.9% NaCl) initially
• Pediatric dosing: 1.5 times 24-hour maintenance requirements (5 mL/kg/h); do not exceed 2 times maintenance 1
• Adjust based on hydration status and serum sodium 1

Cerebral edema warning: Avoid overly rapid fluid administration and osmotic shifts, especially in children. Use gradual correction of glucose and osmolality with judicious isotonic or hypotonic saline based on sodium levels 1.

Step 2: Insulin Therapy

For Moderate-to-Severe DKA:

Continuous IV insulin infusion is preferred (Grade B recommendation) 1

• Target glucose decline: 50-75 mg/dL per hour
• If glucose not declining adequately, double insulin infusion hourly until target achieved 1

For Mild DKA Only:

Subcutaneous or intramuscular regular insulin is equally effective 1:

• Priming dose: 0.4-0.6 units/kg (half IV bolus, half SC/IM)
• Maintenance: 0.1 unit/kg SC or IM every hour

Step 3: Potassium Replacement

• Add potassium to IV fluids: 1/3 as potassium phosphate (KPO₄) and 2/3 as potassium chloride or acetate 1
• Monitor closely as insulin drives potassium intracellularly

Step 4: Phosphate Consideration

Routine phosphate replacement does NOT improve clinical outcomes (Grade A evidence). However, consider careful replacement when serum phosphate <1.0 mg/dL AND patient has cardiac dysfunction, anemia, or respiratory depression to prevent muscle weakness 1.

Step 5: Bicarbonate Therapy

Only consider bicarbonate if pH <6.9 (Grade C recommendation). Bicarbonate is NOT necessary if pH ≥7.0 1. The evidence for benefit is limited even in severe acidosis.

Resolution Criteria

DKA is resolved when ALL of the following are met:

• Glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH ≥7.3 1

Ketonemia clears more slowly than hyperglycemia—don't stop treatment prematurely based on glucose alone 1.

Transition to Subcutaneous Insulin: Critical Timing

Once DKA resolves:

• Continue IV insulin for 1-2 hours AFTER starting subcutaneous insulin to ensure adequate plasma levels and prevent rebound hyperglycemia
• If patient NPO: continue IV insulin with supplemental SC regular insulin every 4 hours (5-unit increments per 50 mg/dL above 150 mg/dL, up to 20 units for glucose 300 mg/dL)
• When eating: initiate multi-dose regimen with short/rapid-acting plus intermediate/long-acting insulin 1

Common pitfall: Abruptly stopping IV insulin without adequate SC insulin overlap leads to poor glycemic control and potential DKA recurrence 1.

Special Considerations

Euglycemic DKA

Be aware of SGLT2 inhibitor-associated DKA, which can present with glucose <250 mg/dL but still have severe ketoacidosis 4, 5. Don't dismiss DKA diagnosis based on "normal" glucose alone.

Precipitating Factors to Address

Identify and treat:

• Infections (most common)
• Insulin non-adherence
• New-onset diabetes
• SGLT2 inhibitor use 5

High-Risk Populations Requiring Modified Approach

• Pregnancy: More aggressive monitoring needed
• Chronic kidney disease: Adjust fluid and electrolyte management
• Heart failure: Careful fluid resuscitation to avoid volume overload
• Elderly patients: Higher mortality risk, require closer monitoring 6